SCHEMBL4987252

SCHEMBL4987252

COc1ccc(-n2nc(C(=O)NCC(C)(C)C)nc2-c2ccc(C#N)cn2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 4/20 0.38
ALDH1A1 P00352 4/20 0.38
AVPR1A P37288 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
SMO Q99835 1/20 0.36
NR3C1 P04150 1/20 0.35
TNF P01375 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SRC P12931 1/20 0.34
SYK P43405 1/20 0.34
MAPK12 P53778 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4987232 0.89 AR (0.40) OXTRALDH1A1AVPR1ANPSR1KDM4E
SCHEMBL4982105 0.89 SMO (0.38) ALDH1A1SMOTNFMEN1NPC1
SCHEMBL4986965 0.86 OXTR (0.39) OXTRALDH1A1AVPR1ANPSR1KDM4E
SCHEMBL4984606 0.85 SMO (0.38) OXTRALDH1A1AVPR1ASMOTNF
SCHEMBL4988506 0.85 OXTR (0.40) OXTRALDH1A1AVPR1ANPSR1KDM4E
SCHEMBL4990363 0.84 ALDH1A1 (0.39) ALDH1A1SMOMEN1NPC1RAB9A
SCHEMBL14215218 0.78 OXTR (0.43) OXTRALDH1A1AVPR1AKDM4EHPGD
SCHEMBL4990555 0.78 MEN1 (0.38) SMOMEN1NPC1RAB9AKMT2A
SCHEMBL4987425 0.77 HPGD (0.36) OXTRALDH1A1AVPR1AHPGDTSHR
SCHEMBL4987655 0.76 P2RX7 (0.39) OXTRAVPR1ASMONR3C1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125409-A1 1,5-Diheterocycle-1H-Triazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-05-29 US disclosed
EP-1803719-A1 1,5-DIHETEROCYCLE-1H-TRIAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125409-A1 1,5-Diheterocycle-1H-Triazole Derivative PTGS1, PTGER1, TBXA2R OXTR 2187/4885ALDH1A1 185/4885AVPR1A 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.